GlassScriptPhysician profile
Vladimir Birjiniuk
NPI 1952376626
$1,117.77
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $58.87 · 2021: $118 · 2022: $430 · 2023: $220 · 2024: $30.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $325.97 | 2021-2022 | |
| Pfizer INC. | $263.78 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $243.12 | 2019-2023 | |
| Boston Scientific Corporation | $83.01 | 2023 | Ekosonic |
| Amgen INC. | $75.41 | 2021-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $74.35 | 2019-2022 | |
| Ethicon INC. | $32.09 | 2023 | Monarch Platform |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vladimir Birjiniuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.